SynthesisCurrent oncology (Toronto, Ont.)2022

Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis.

Francesco Fiorica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.